1383377-01-2Relevant articles and documents
Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors
Wager, Travis T.,Galatsis, Paul,Chandrasekaran, Ramalakshmi Y.,Butler, Todd W.,Li, Jianke,Zhang, Lei,Mente, Scot,Subramanyam, Chakrapani,Liu, Shenping,Doran, Angela C.,Chang, Cheng,Fisher, Katherine,Grimwood, Sarah,Hedde, Joseph R.,Marconi, Michael,Schildknegt, Klaas
, p. 1995 - 2004 (2017/09/25)
To enable the clinical development of our CNS casein kinase 1 delta/epsilon (CK1δ/e) inhibitor project, we investigated the possibility of developing a CNS positron emission tomography (PET) radioligand. For this effort, we focused our design and synthesis efforts on the initial CK1δ/e inhibitor HTS hits with the goal of identifying a compound that would fulfill a set of recommended PET ligand criteria. We identified [3H]PF-5236216 (9) as a tool ligand that meets most of the key CNS PET attributes including high CNS MPO PET desirability score and kinase selectivity, CNS penetration, and low nonspecific binding. We further used [3H]-9 to determine the binding affinity for PF-670462, a literature CK1δ/e inhibitor tool compound. Lastly, [3H]-9 was used to measure in vivo target occupancy (TO) of PF-670462 in mouse and correlated TO with CK1δ/e in vivo pharmacology (circadian rhythm modulation).
